Related Experiment Video

Updated: May 25, 2026

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease
15:09

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease

Published on: October 3, 2012

Mao-B elevation decreases parkin's ability to efficiently clear damaged mitochondria: protective effects of rapamycin

Almas Siddiqui1, Ingrid Hanson, Julie K Andersen

  • 1Buck Institute for Research in Aging, Novato, CA, USA.

Free Radical Research
|February 15, 2012
PubMed

Insights

Elevated monoamine oxidase B (MAO-B) in Parkinson

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Oxidative stress in Parkinson's disease (PD) substantia nigra is linked to neurodegeneration.
  • Elevated monoamine oxidase B (MAO-B) and inhibited parkin E3 ligase activity are implicated in PD pathogenesis.
  • Parkin dysfunction affects mitochondrial quality control and turnover.

Purpose of the Study:

  • To investigate the impact of induced monoamine oxidase B (MAO-B) on parkin E3 ligase activity and mitochondrial function.
  • To determine if rapamycin can restore mitochondrial function and mitophagy in a cellular model of PD.

Main Methods:

  • Utilized an inducible MAO-B cell model to study Parkinson's disease mechanisms.
  • Assessed parkin E3 ligase activity, mitochondrial turnover, and mitochondrial function.
  • Investigated the effect of the mTOR inhibitor rapamycin on cellular processes.

Main Results:

  • MAO-B induction led to decreased parkin E3 ligase activity, reduced mitochondrial turnover, and impaired mitochondrial function.
  • Parkin's translocation to damaged mitochondria remained unaffected.
  • Rapamycin treatment restored mitophagy and mitochondrial function in the MAO-B-induced cells.

Conclusions:

  • MAO-B induction disrupts mitochondrial quality control by impairing parkin activity and mitochondrial turnover.
  • Rapamycin shows potential in counteracting the loss of parkin function by promoting autophagic clearance of damaged mitochondria.
  • These findings highlight a potential therapeutic strategy for Parkinson's disease targeting mitochondrial dysfunction.

More Related Videos

Time-Lapse Video Microscopy for Assessment of EYFP-Parkin Aggregation as a Marker for Cellular Mitophagy09:29

Time-Lapse Video Microscopy for Assessment of EYFP-Parkin Aggregation as a Marker for Cellular Mitophagy

Published on: May 4, 2016

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...